Dry Eye Products Market Growth Sturdy at 4.8% CAGR to Outstrip $9,141.01 Million by 2027 - COVID-19 Impact and Global Analysis by TheInsightPartners.com
07 mai 2021 09h30 HE
|
The Insight Partners
Pune, India., May 07, 2021 (GLOBE NEWSWIRE) -- Dry Eye Products Market: Key InsightsAccording to our new research study on “Dry Eye Products Market to 2027 – Global Analysis and Forecast – by...
I-MED Pharma launches tearcheck® in Canada - A new standard in dry eye analysis
10 nov. 2020 10h20 HE
|
I-MED Pharma
MONTREAL, Nov. 10, 2020 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, announces the launch of tearcheck®, a new Health Canada approved...
Patented IRPL® Technology Now Available in Canada!
27 avr. 2020 10h48 HE
|
I-MED Pharma
MONTREAL, April 27, 2020 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is proud to announce Health Canada approval for the E>Eye...
I-MED Pharma to Launch Its Most Advanced Artificial Tear to Date With I-DROP® MGD
03 févr. 2020 14h11 HE
|
I-MED Pharma
MONTREAL, Feb. 03, 2020 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, announced today that the company has plans to launch its newest,...
Federal Court of Appeal Upholds I-MED Pharma’s Patent Win Against TearLab
17 juin 2019 11h05 HE
|
I-MED Pharma
MONTREAL, June 17, 2019 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, announced today that the Canadian Federal Court of Appeal...
I-MED Pharma Becomes the Authorized Canadian Distributor for the OrCam MyEye 2
10 avr. 2019 11h11 HE
|
I-MED Pharma
MONTREAL, April 10, 2019 (GLOBE NEWSWIRE) -- I-MED Pharma, Inc., a Canadian company specializing in dry eye diagnosis and management is proud to announce the signing of an authorized Canadian...
I-MED Pharma Celebrates 30 Years of Providing OSD & Surgical Solutions to the Global Eye Care Community
01 avr. 2019 10h22 HE
|
I-MED Pharma
MONTREAL, April 01, 2019 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, proudly announces its 30-year anniversary providing OSD &...
I-PEN® Osmolarity System Now Available in Brazil Through Partnership with DryCom
26 mars 2019 13h42 HE
|
I-MED Pharma
MONTREAL, March 26, 2019 (GLOBE NEWSWIRE) -- I-MED Pharma, Inc., a Canadian company specializing in dry eye diagnosis and management, announced today the signing of an exclusive agreement with...
I-MED Pharma Partners with Simovision to Bring the I-PEN® Osmolarity System to Belgium, Luxembourg & the Netherlands
02 oct. 2018 10h54 HE
|
I-MED Pharma
MONTREAL, Oct. 02, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of an exclusive agreement with...
I-MED Pharma Inc. Announces Partnership with Medicals International
23 juil. 2018 11h41 HE
|
I-MED Pharma
MONTREAL, July 23, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of an exclusive agreement with...